| 1 |
Stephan Roever |
Hoffmann-La Roche |
9 |
| 2 |
Anna Vulpetti |
Novartis Ag |
7 |
| 3 |
Ravi Jagasia |
Hoffmann-La Roche |
6 |
| 3 |
Raphael Beumer |
Dsm Ip Assets B.V. |
6 |
| 3 |
Simona M. Ceccarelli |
Hoffmann-La Roche |
6 |
| #6 |
Heinz Stadler |
Hoffmann-La Roche |
5 |
| #6 |
Georg Jaeschke |
Hoffmann-La Roche |
5 |
| #6 |
Johannes Tschumi |
Dsm Ip Assets B.V. |
5 |
| #6 |
Hans-Peter Maerki |
Hoffmann-La Roche |
5 |
| #6 |
Edoardo Menozzi |
Basf Se |
5 |
| #6 |
Lothar Lindemann |
Hoffmann-La Roche |
5 |
| #12 |
Bahaa Salem |
Novartis Ag |
4 |
| #12 |
Frank Schaefer |
Robert Bosch Gmbh |
4 |
| #12 |
Sebastian Dziadek |
Roche Diagnostics Operations |
4 |
| #12 |
Enrico Galfre |
Basf Se |
4 |
| #12 |
Darryl Brynley Jones |
Novartis Ag |
4 |
| #17 |
Urs Lehmann |
Ciba Specialty Chemicals |
3 |
| #17 |
Martin Szelagiewicz |
Basf Se |
3 |
| #17 |
Dorte Renneberg |
Actelion Pharmaceuticals |
3 |
| #17 |
Alexander Baxter Smith |
Novartis Ag |
3 |
| #17 |
Angela Wildermann |
Dsm Ip Assets B.V. |
3 |
| #17 |
Dirk Weber |
Dsm Ip Assets B.V. |
3 |
| #17 |
Roger Norcross |
Hoffmann-La Roche |
3 |
| #17 |
Bettina Wüstenberg |
Dsm Ip Assets B.V. |
3 |
| #17 |
John Geurts |
Dsm Ip Assets B.V. |
3 |
| #17 |
Swaroop K. Vakkalanka |
Rhizen Pharmaceuticals Ag |
3 |
| #17 |
Robert Alexander Pulz |
Novartis Ag |
3 |
| #17 |
Hasane Ratni |
Hoffmann-La Roche |
3 |
| #17 |
Philipp Brun |
Depuy Synthes Products |
3 |
| #17 |
Daniel E. Gerard |
Omya International Ag |
3 |
| #17 |
Marcus Meier |
Straumann Holding Ag |
3 |
| #17 |
Axel Buss |
Dsm Ip Assets B.V. |
3 |
| #17 |
Jan Schütz |
Dsm Ip Assets B.V. |
3 |
| #17 |
Juana-Lucia Flores-Candia |
Dsm Ip Assets B.V. |
3 |
| #17 |
Michelle Richert |
Basf Se |
3 |
| #36 |
Serena Maria Fantasia |
Hoffmann-La Roche |
2 |
| #36 |
Grahame Woollam |
Theravance Biopharma R&D Ip |
2 |
| #36 |
Cinzia Tartarini |
Basf Se |
2 |
| #36 |
Regina Goralczyk |
Dsm Ip Assets B.V. |
2 |
| #36 |
Marko Loparic |
University Of Basel |
2 |
| #36 |
Marija Plodinec |
University Of Basel |
2 |
| #36 |
Simone Koenig-Grillo |
Dsm Ip Assets B.V. |
2 |
| #36 |
Thomas Clavey |
Dsm Ip Assets B.V. |
2 |
| #36 |
Achim Schlapbach |
Novartis Ag |
2 |
| #36 |
Paolo Fancelli |
Stoll Giroflex Ag |
2 |
| #36 |
Paul Hebeisen |
Hoffmann-La Roche |
2 |
| #36 |
Anthony Cornelius O'Sullivan |
Syngenta Crop Protection Ag |
2 |
| #36 |
Ian James Matthews |
Resmed |
2 |
| #36 |
Catherine Leblanc |
Novartis Ag |
2 |
| #36 |
Richard Sedrani |
Novartis Ag |
2 |